ROBERT ELLIS: Open Payments
NPI 1902284599 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 7 payments from 6 companies in 2025. Trend: 2023 $48 · 2024 $134 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 1 | $113 |
| Janssen Biotech, Inc. | 2 | $47 |
| Astellas Pharma US Inc | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Caris MPI, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
Products named: ORGOVYX, ERLEADA, Cresemba, PLUVICTO, MI CANCER SEEK, ADSTILADRIN.
Industry payments across AZ — which companies pay providers there.
